Progenics Pharmaceuticals Down 20.7% Since SmarTrend Downtrend Call (PGNX)

SmarTrend identified a Downtrend for Progenics Pharmaceuticals (NASDAQ:PGNX) on August 7th, 2015 at $7.83. In approximately 2 months, Progenics Pharmaceuticals has returned 20.69% as of today's recent price of...